Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.

The safety of statins in clinical practice

Armitage, Jane · 2007 · The Lancet

Abstract

Statins are effective cholesterol-lowering drugs that reduce the risk of cardiovascular disease events (heart attacks, strokes, and the need for arterial revascularisation). Adverse effects from some statins on muscle, such as myopathy and rhabdomyolysis, are rare at standard doses, and on the liver, in increasing levels of transaminases, are unusual. Myopathy--muscle pain or weakness with blood creatine kinase levels more than ten times the upper limit of the normal range--typically occurs in fewer than one in 10,000 patients on standard statin doses. However, this risk varies between statins, and increases with use of higher doses and interacting drugs. Rhabdomyolysis is a rarer and more severe form of myopathy, with myoglobin release into the circulation and risk of renal failure. Stopping statin use reverses these side-effects, usually leading to a full recovery. Asymptomatic increases in concentrations of liver transaminases are recorded with all statins, but are not clearly associated with an increased risk of liver disease. For most people, statins are safe and well-tolerated, and their widespread use has the potential to have a major effect on the global burden of cardiovascular disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)60716-8

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 130 references

Research works printed but not linked: 2

  1. Peto, 1985, Cholesterol lowering trials in their epidemiological context, Circulation, 72, 451
  2. Krum, 2002, Statins and chronic heart faliure: do we need a large-scale outcome trial?, J Am Coll Cardiol, 8, 216

Cited by

See all 843

Metadata

Authors
Armitage, J.
Affiliations
University of Oxford (GB)
Corresponding author
Armitage, Jane
Venue
The Lancet
Publisher
Elsevier BV
Published
2007-11
Volume
370
Issue
9601
Pages
1781-1790
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1976358806
Cited by
833
References
130
Citations by year
2026: 8 · 2025: 13 · 2024: 27 · 2023: 28 · 2022: 20 · 2021: 29 · 2020: 31 · 2019: 48 · 2018: 41 · 2017: 52 · 2016: 57 · 2015: 62 · 2014: 62 · 2013: 67 · 2012: 48
FWCI
10.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
statins, drug safety, myopathy, rhabdomyolysis, creatine kinase, liver transaminases, drug interactions, statin dose, adverse drug reactions, cardiovascular disease prevention, cholesterol-lowering drugs
MeSH terms
Dose-Response Relationship, Drug, Drug Interactions, Humans, Hypercholesterolemia, Liver, Rhabdomyolysis, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The safety of statins in clinical practice. https://app.cochat.ai/papers/10.1016/s0140-6736(07)60716-8
The paper
Armitage, J. (2007). The safety of statins in clinical practice. The Lancet. https://doi.org/10.1016/s0140-6736(07)60716-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.